BEER SHEVA, Israel, June 20, 2017 /PRNewswire/ --
DiACardio, makers of next generation imaging analysis technology, today announced it is changing its name to DiA Imaging Analysis ("DiA"). DiA has expanded its strategic mission to include a broader set of medical imaging analysis solutions, in addition to its original focus on echocardiography.
The name change and new brand reflects the dynamic growth of DiA to date and secures its leadership position as it continues on its mission to deliver innovative imaging analysis solutions to improve patient care.
This past year the company has received FDA and CE clearances for two additional unique cardio imaging analysis solutions and was announced by The Personal Connected Health Alliance (PCHAlliance) as the winner of its 11th annual Venture+Forum pitch competition at the 2017 HIMSS Annual Conference & Exhibition.
"By acquiring FDA and CE clearance for our initial cardiac - auto toolbox, we have proved the concept," said Hila Goldman Aslan, the company's CEO and Co-founder. "We have recognized that our core technology can be used to offer quick and accurate solutions to the imaging world beyond cardiology. We are now both accelerating our cardio toolbox development and expanding into additional segments."
About DIA Imaging Analysis
DiA Imaging Analysis Ltd. is a medical imaging analysis software company, providing fully automated, easily implemented supporting tools that enable quick, objective and accurate image interpretations with initial focus on ultrasound of the heart (Echocardiography).
DiA's cognitive image processing technology is based on advanced pattern recognition and machine learning algorithms that automatically imitate the way the human eye identifies borders and motion, and produce data and scoring, physicians are looking for.
Headquartered in Beer-Sheva, Israel and present in the US, DiA is led by medical industry veterans, experienced entrepreneurs and supported by key opinion leaders from top medical facilities in the USA and Israel.
SOURCE DIA Imaging Analysis Ltd.